NOP53 undergoes liquid-liquid phase separation and promotes tumor radio-resistance

Jie Shi1,2, Si-Ying Chen2,3, Xiao-Ting Shen4

  • 1Department of Radiation Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, P.R. China.

Cell Death Discovery
|November 1, 2022
PubMed

Insights

Nucleolar protein NOP53 drives tumor radio-resistance by regulating the DNA damage response. Silencing NOP53 sensitizes colorectal cancer cells to radiotherapy, offering a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Aberrant DNA damage response (DDR) is a key mechanism of tumor radio-resistance.
  • Liquid-liquid phase separation (LLPS) is an emerging DDR mechanism.
  • NOP53 is a nucleolar protein implicated in DDR.

Purpose of the Study:

  • To investigate the role of NOP53 in DDR and radio-resistance.
  • To characterize the biophysical properties and regulation of NOP53 LLPS.
  • To explore NOP53 as a potential therapeutic target for colorectal cancer (CRC).

Main Methods:

  • In vivo and in vitro assays to assess NOP53 phase separation properties.
  • Analysis of intrinsically disordered regions (IDRs) and linear motifs (M-R motifs).
  • Functional assays including NOP53 silencing and assessment of p53 pathway activity.
  • Correlation analysis with clinical samples.

Main Results:

  • NOP53 forms liquid-like droplets in vitro and in vivo.
  • The intrinsically disordered region 1 (IDR1) is essential for NOP53 LLPS.
  • NOP53 silencing reduces tumor cell growth and sensitizes CRC cells to radiotherapy.
  • NOP53 negatively regulates the p53 pathway and correlates with tumor radio-resistance in clinical samples.

Conclusions:

  • NOP53 plays a critical role in tumor radio-resistance through LLPS and p53 pathway regulation.
  • NOP53 is a potential therapeutic target for enhancing radiotherapy efficacy in colorectal cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...